239 related articles for article (PubMed ID: 16546744)
1. [Association of HER-2/neu expression with prognosis of gastric cancer].
Chen B; Luo RC; Cui F; Qian XY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
[TBL] [Abstract][Full Text] [Related]
2. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
5. [Transcription factor Sp1 expression in gastric cancer and its prognostic value].
Zhang J; Ji J; Yuan F; Chen J; Yan M; Yu YY; Liu BY; Yin HR; Lin YZ; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):531-3. PubMed ID: 16438849
[TBL] [Abstract][Full Text] [Related]
6. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844
[TBL] [Abstract][Full Text] [Related]
7. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
Peredo R; Sastre G; Serrano J; Hunter Mellado R
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinoma.
Tanabe H; Nishii H; Sakata A; Suzuki K; Mori Y; Shinozaki H; Watanabe A; Ochiai K; Yasuda M; Tanaka T
Gynecol Oncol; 2004 Sep; 94(3):735-9. PubMed ID: 15350366
[TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
Peláez Buján Mdel C; Ruibal Morell A; Aza González J
Rev Esp Enferm Dig; 1999 Dec; 91(12):826-37. PubMed ID: 10619912
[TBL] [Abstract][Full Text] [Related]
10. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
[TBL] [Abstract][Full Text] [Related]
11. [mRNA expression of basic fibroblast growth factor and hepatocyte growth factor in gastric carcinoma and significance thereof].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2030-5. PubMed ID: 19080429
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma].
Gong Z; Luo E; Lu Q
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):299-301. PubMed ID: 9387327
[TBL] [Abstract][Full Text] [Related]
13. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
Lee EY; Cibull ML; Strodel WE; Haley JV
Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
[TBL] [Abstract][Full Text] [Related]
14. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
16. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
17. High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival.
Cao W; Zhang B; Liu Y; Li H; Zhang S; Fu L; Niu Y; Ning L; Cao X; Liu Z; Sun B
Am J Clin Pathol; 2007 Sep; 128(3):430-6. PubMed ID: 17709317
[TBL] [Abstract][Full Text] [Related]
18. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of nm23 gene expression in gastric cancer.
Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]